LRRK2 and Parkinson disease: Looking upon Parkinson’s disease, iPSCs carrying LRRK2 G2019S mutation were isolated from patients to develop human neuroectodermal spheres which showed the synaptic dysfunction pathway to be the most altered pathway in Parkinson’s disease PDOs.